This segment focuses on the development, manufacturing, and supply of high-quality APIs for various therapeutic applications. Research and development efforts are directed towards optimizing synthesis processes, improving drug purity, and developing novel APIs. The company employs advanced chemical synthesis techniques and adheres to stringent quality control measures to ensure compliance with international regulatory standards. APIs produced in this segment are used in a wide range of pharmaceutical formulations, addressing conditions in cardiovascular health, central nervous system disorders, and infectious diseases. Huahai's market positioning is strengthened by its ability to offer cost-effective and reliable API solutions to global pharmaceutical companies, fostering partnerships and collaborations for future growth.

This segment involves the research, development, production, and commercialization of generic drug products. The company focuses on developing generic versions of off-patent drugs, providing affordable treatment options for patients. R&D activities include formulation development, bioequivalence studies, and regulatory submissions. Huahai leverages its expertise in API manufacturing to ensure a reliable supply chain for its generic products. The therapeutic areas covered include cardiovascular diseases, central nervous system disorders, and anti-infectives. The company's market positioning is enhanced by its ability to offer high-quality generic drugs at competitive prices, addressing unmet medical needs and improving patient access to essential medicines. Future opportunities include expanding the generic product portfolio and entering new markets.

This segment provides comprehensive contract manufacturing services to pharmaceutical companies, supporting them in various stages of drug development and commercialization. Services include process development, scale-up, formulation development, analytical testing, and manufacturing of drug products. Huahai leverages its state-of-the-art facilities and experienced workforce to offer customized solutions to meet the specific needs of its clients. The company adheres to strict quality standards and regulatory requirements, ensuring the safety and efficacy of manufactured products. This segment allows Huahai to leverage its manufacturing capabilities and expertise to generate revenue and build long-term partnerships with pharmaceutical companies. Future growth potential lies in expanding the range of CMO services and attracting new clients.